Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.27%122.84B | 17.11%492.24B | 16.78%115.59B | 9.88%420.31B | 15.85%107.86B | 1.04%105.17B | 15.82%108.29B | 7.78%98.99B | 5.40%382.54B | 11.65%93.1B |
| Cost of revenue | -10.53%13.88B | 18.23%69.42B | 18.39%15.52B | -1.98%58.71B | 19.56%15.03B | -40.30%11.52B | 36.18%19.05B | -6.63%13.11B | -6.31%59.9B | 22.02%12.57B |
| Gross profit | 8.88%108.96B | 16.93%422.82B | 16.53%100.08B | 12.08%361.6B | 15.27%92.83B | 10.45%93.65B | 12.24%89.24B | 10.38%85.88B | 7.90%322.64B | 10.18%80.53B |
| Operating expense | 2.31%63.45B | 7.79%261.7B | 8.72%62.01B | 6.31%242.78B | 5.83%67.23B | 6.35%59.43B | 6.55%59.09B | 6.24%57.04B | 2.62%228.37B | -8.26%63.52B |
| Selling and administrative expenses | 2.31%63.45B | 7.79%261.7B | 8.72%62.01B | 6.31%242.78B | 5.83%67.23B | 6.35%59.43B | 6.55%59.09B | 6.24%57.04B | 2.62%228.37B | -8.26%63.52B |
| -General and administrative expense | 2.31%63.45B | 7.79%261.7B | 8.72%62.01B | 6.31%242.78B | 5.83%67.23B | 6.35%59.43B | 6.55%59.09B | 6.24%57.04B | 2.62%228.37B | -8.26%63.52B |
| Operating profit | 19.58%45.52B | 35.59%161.12B | 31.98%38.06B | 26.05%118.83B | 50.52%25.61B | 18.38%34.23B | 25.35%30.15B | 19.61%28.84B | 23.27%94.27B | 342.33%17.01B |
| Net non-operating interest income (expenses) | -54.73%-12.12B | -59.74%-39.77B | -54.47%-7.83B | -63.18%-24.9B | -62.66%-7.39B | -76.12%-6.62B | -52.24%-5.81B | -61.74%-5.07B | -33.12%-15.26B | -45.39%-4.55B |
| Non-operating interest expense | 54.73%12.12B | 59.74%39.77B | 54.47%7.83B | 63.18%24.9B | 62.66%7.39B | 76.12%6.62B | 52.24%5.81B | 61.74%5.07B | 33.12%15.26B | 45.39%4.55B |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 32.28%504M | 129.07%662M | 301.05%381M | 572.09%289M | 160.47%112M | 54M | 27M | 95M | 43M | 43M |
| Income from associates and other participating interests | 60.76%4.15B | -55.47%13.03B | 65.32%2.58B | 389.17%29.26B | 277.79%2.84B | 162.29%3.37B | 1,037.37%21.49B | -23.87%1.56B | 30.38%5.98B | -41.75%752M |
| Special income (charges) | -22.56%-14.99B | -13.05%-43.28B | -48.60%-12.23B | -10.62%-38.29B | 29.83%-11.2B | -27.77%-8.08B | -71.77%-10.78B | -35.92%-8.23B | -40.84%-34.61B | -158.38%-15.96B |
| Less:Write off | 22.56%14.99B | 13.05%43.28B | 48.60%12.23B | 10.62%38.29B | -29.83%11.2B | 27.77%8.08B | 71.77%10.78B | 35.92%8.23B | 40.84%34.61B | 158.38%15.96B |
| Other non-operating income (expenses) | -107.75%-202M | -91.93%1.03B | -61.70%2.61B | 20.15%12.76B | 664.34%4.21B | -67.14%1.45B | -85.15%291M | 31.40%6.81B | 116.25%10.62B | -516.53%-746M |
| Income before tax | -3.02%22.87B | -5.27%92.79B | -1.80%23.58B | 60.46%97.95B | 511.64%14.18B | -0.49%24.4B | 98.59%35.36B | 8.36%24.01B | 22.24%61.04B | 19.66%-3.44B |
| Income tax | -0.90%6.7B | 3.11%25.44B | -2.94%6.76B | 43.55%24.67B | 282.57%3.29B | -6.50%6.19B | 51.17%8.23B | 0.55%6.97B | 19.80%17.18B | 50.81%-1.8B |
| Net income | -3.87%16.17B | -8.10%67.35B | -1.33%16.82B | 67.08%73.29B | 763.09%10.89B | 1.73%18.22B | 119.46%27.14B | 11.91%17.04B | 23.23%43.86B | -163.56%-1.64B |
| Net income continuous operations | -3.87%16.17B | -8.10%67.35B | -1.33%16.82B | 67.08%73.29B | 763.09%10.89B | 1.73%18.22B | 119.46%27.14B | 11.91%17.04B | 23.23%43.86B | -163.56%-1.64B |
| Noncontrolling interests | -68.64%69M | 219.46%952M | 141.76%220M | 14.18%298M | -255.56%-42M | 22.46%169M | 77.27%78M | 78.43%91M | 19.72%261M | 164.29%27M |
| Net income attributable to the company | -3.01%16.1B | -9.03%66.4B | -2.09%16.6B | 67.41%72.99B | 754.88%10.93B | 1.56%18.05B | 119.62%27.06B | 11.68%16.95B | 23.25%43.6B | -187.76%-1.67B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -3.01%16.1B | -9.03%66.4B | -2.09%16.6B | 67.41%72.99B | 754.88%10.93B | 1.56%18.05B | 119.62%27.06B | 11.68%16.95B | 23.25%43.6B | -187.76%-1.67B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 6.56%108.85 | -6.63%423.02 | -5.79%102.15 | 62.44%453.08 | 721.54%66.38 | -2.74%110.56 | 112.52%167.51 | 11.66%108.43 | 23.23%278.92 | -187.10%-10.68 |
| Diluted earnings per share | 6.67%108.85 | -6.74%422.19 | -5.86%102.04 | 62.40%452.69 | 719.57%66.17 | -2.65%110.49 | 112.78%167.44 | 11.80%108.39 | 23.27%278.75 | -181.05%-10.68 |
| Dividend per share | 0 | 41.18%120 | 0 | 21.43%85 | 21.43%85 | 0 | 0 | 0 | 27.27%70 | 27.27%70 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |